Related Experiment Video
Updated: Jan 14, 2026

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
TET enzymes: Involvement in cancer development and therapeutical perspectives
Tarik Aanniz1, Meriem El Fessikh2, Jihane Touhtouh3
1Medical Biotechnology Laboratory, Rabat Medical & Pharmacy School, Mohammed V University in Rabat, Rabat, B.P. 6203, Morocco.
Abstract:
The TET family of enzymes is essential for the dynamic regulation of DNA methylation and the epigenetic landscape of human genomes. Their ability to oxidize 5-methylcytosine (5mC) into various hydroxymethylated derivatives facilitates active DNA demethylation and serves as a critical regulatory mechanism in normal cellular processes. Dysregulation of TET proteins has been implicated in multiple types of cancer, highlighting their significance in tumorigenesis and their potential for therapeutic targeting. The functionality of TET proteins continues to be widely studied across various tissues and contexts. Their role as novel drug targets in cancer therapy is attracting increasing attention. Understanding how TET enzymes contribute to epigenetic alterations could provide new insights into cancer prevention and treatment, potentially extending the window of effective therapeutic intervention. This review aims to explore the diverse roles and regulatory mechanisms of TET proteins, examine how their dysregulation promotes cancer progression, and underscore the potential of TET enzymes as druggable targets for anticancer therapy.
Insights
The TET family of enzymes regulates DNA methylation and epigenetics. Their dysregulation is linked to cancer, making them promising therapeutic targets for new anticancer treatments.
Area of Science:
- Epigenetics
- Molecular Biology
- Cancer Research
Background:
- The TET (ten-eleven translocation) enzyme family is crucial for dynamic DNA methylation regulation in human genomes.
- TET enzymes oxidize 5-methylcytosine (5mC) to hydroxymethylated derivatives, enabling active DNA demethylation and regulating cellular processes.
Purpose of the Study:
- To explore the diverse roles and regulatory mechanisms of TET proteins.
- To examine how TET protein dysregulation contributes to cancer progression.
- To highlight the potential of TET enzymes as druggable targets for anticancer therapy.
Main Methods:
- Literature review of studies on TET enzyme function, regulation, and involvement in cancer.
- Analysis of epigenetic alterations associated with TET protein dysregulation.
- Examination of current and emerging therapeutic strategies targeting TET enzymes.
Main Results:
- TET proteins are essential for maintaining epigenetic stability and normal cellular function.
- Dysregulation of TET enzymes is implicated in the development and progression of various cancers.
- TET enzymes represent a significant area of research for novel cancer therapies.
Conclusions:
- Understanding TET enzyme functions and dysregulation provides critical insights into cancer biology.
- Targeting TET enzymes offers a promising avenue for developing effective anticancer therapies.
- Further research into TET proteins could lead to improved cancer prevention and treatment strategies.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Mitogens and the Cell Cycle
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer
The Tumor Microenvironment

